These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3440863)

  • 1. A self-controlled study of the effect of continuous subcutaneous insulin infusion on diabetic neuropathy.
    Haug PJ; Kelly TM; Cannon RB; Edwards CQ
    J Neurol Sci; 1987 Dec; 82(1-3):123-32. PubMed ID: 3440863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of near-normoglycaemia for 4 years on somatic nerve dysfunction and heart rate variation in type 1 diabetic patients.
    Ziegler D; Dannehl K; Wiefels K; Gries FA
    Diabet Med; 1992; 9(7):622-9. PubMed ID: 1511568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of one year of near-normoglycemia on peripheral nerve function in type 1 (insulin-dependent) diabetic patients.
    Ziegler D; Wiefels K; Dannehl K; Gries FA
    Klin Wochenschr; 1988 May; 66(9):388-96. PubMed ID: 2839729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing glucose variability with continuous subcutaneous insulin infusion is associated with reversal of axonal dysfunction in type 1 diabetes mellitus.
    Kamel J; Loh M; Cook M; MacIsaac RJ; Roberts LJ
    Muscle Nerve; 2020 Jan; 61(1):44-51. PubMed ID: 31613996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy.
    Boulton AJ; Drury J; Clarke B; Ward JD
    Diabetes Care; 1982; 5(4):386-90. PubMed ID: 7151654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of diabetic peripheral neuropathy with the portable insulin infusion pump.
    Tolaymat A; Roque JL; Russo LS
    South Med J; 1982 Feb; 75(2):185-9. PubMed ID: 7036357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of continuous subcutaneous insulin infusion (CSII) treatment on diabetic somatic and autonomic neuropathy.
    Fedele D; Negrin P; Cardone C; Bellavere F; Ferri M; Briani G; Nosadini R; Crepaldi G
    J Endocrinol Invest; 1984 Dec; 7(6):623-8. PubMed ID: 6530514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical nerve dysfunction in children and adolescents with IDDM.
    Hyllienmark L; Brismar T; Ludvigsson J
    Diabetologia; 1995 Jun; 38(6):685-92. PubMed ID: 7672490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased nerve conduction in diabetics after a year of improved glucoregulation.
    Ehle AL; Raskin P
    J Neurol Sci; 1986 Jul; 74(2-3):191-7. PubMed ID: 3525757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic neuropathy: effects of intensified glycaemic control with multiple insulin injections.
    Hotta N; Kawamori R; Sano T; Kakuta H; Kamada T; Sakamoto N
    Diabet Med; 1993; 10 Suppl 2():91S-94S. PubMed ID: 8334854
    [No Abstract]   [Full Text] [Related]  

  • 11. Peripheral nerve function in patients with painful diabetic neuropathy treated with continuous subcutaneous insulin infusion.
    Bertelsmann FW; Heimans JJ; Van Rooy JC; Dankmeijer HF; Visser SL; Van der Veen EA
    J Neurol Neurosurg Psychiatry; 1987 Oct; 50(10):1337-41. PubMed ID: 3681313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of continuous subcutaneous infusion and split-mixed injection of insulin on nerve function in type I diabetes mellitus.
    Warmolts JR; Mendell JR; O'Dorisio TM; Cataland S
    J Neurol Sci; 1987 Dec; 82(1-3):161-9. PubMed ID: 3326911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawal of the aldose reductase inhibitor tolrestat in patients with diabetic neuropathy: effect on nerve function. The Tolrestat Study Group.
    Santiago JV; Snksen PH; Boulton AJ; Macleod A; Beg M; Bochenek W; Graepel GJ; Gonen B
    J Diabetes Complications; 1993; 7(3):170-8. PubMed ID: 8343611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of glucoregulation with continuous subcutaneous insulin infusion on nerve conduction velocity and beat to beat variation in diabetics.
    Gambardella S; Napoli A; Spallone V; Verrastro AM; Lazzari R; Geraldini C; Sideri G; Menzinger G
    J Endocrinol Invest; 1983 Oct; 6(5):363-7. PubMed ID: 6663037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral nerve function and metabolic control in diabetes mellitus.
    Troni W; Carta Q; Cantello R; Caselle MT; Rainero I
    Ann Neurol; 1984 Aug; 16(2):178-83. PubMed ID: 6383190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amelioration of nerve conduction velocity following simultaneous kidney/pancreas transplantation is due to the glycaemic control provided by the pancreas.
    Martinenghi S; Comi G; Galardi G; Di Carlo V; Pozza G; Secchi A
    Diabetologia; 1997 Sep; 40(9):1110-2. PubMed ID: 9300250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of use of specific features of subcutaneous insulin infusion systems and their relationship to metabolic control in patients with type 1 diabetes.
    Quirós C; Patrascioiu I; Giménez M; Vinagre I; Vidal M; Jansà M; Conget I
    Endocrinol Nutr; 2014; 61(6):318-22. PubMed ID: 24533929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Impact of Prolonged Use of Continuous Subcutaneous Insulin Infusion in the Control of Type-1 Diabetes].
    Azevedo S; Saraiva J; Caramelo F; Fadiga L; Barros L; Baptista C; Melo M; Gomes L; Carrilho F
    Acta Med Port; 2019 Feb; 32(1):17-24. PubMed ID: 30753799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical value of Flash glucose monitoring in patients with type 1 diabetes treated with continuous subcutaneous insulin infusion.
    Moreno-Fernandez J; Pazos-Couselo M; González-Rodriguez M; Rozas P; Delgado M; Aguirre M; Garcia-Lopez JM
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Dec; 65(10):556-563. PubMed ID: 29907546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of treatment with continuous subcutaneous insulin infusion (CSII) in insulin-dependent (type I) diabetics.
    Felsing W; Bibergeil H; Menzel R; Albrecht G; Felsing U; Dabels J; Reichel G; Lüder C
    Exp Clin Endocrinol; 1984 Apr; 83(2):136-42. PubMed ID: 6373315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.